0001209191-17-053903.txt : 20170926 0001209191-17-053903.hdr.sgml : 20170926 20170926094058 ACCESSION NUMBER: 0001209191-17-053903 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170922 FILED AS OF DATE: 20170926 DATE AS OF CHANGE: 20170926 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wills Robert James CENTRAL INDEX KEY: 0001634189 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36500 FILM NUMBER: 171101035 MAIL ADDRESS: STREET 1: 175 TOYOTA PLAZA, 7TH FLOOR CITY: MEMPHIS STATE: TN ZIP: 38103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-09-22 0 0001042074 CymaBay Therapeutics, Inc. CBAY 0001634189 Wills Robert James C/O CYMABAY THERAPEUTICS, INC. 7999 GATEWAY BOULEVARD, SUITE 130 NEWARK CA 94560 1 0 0 0 Stock Option (right to buy) 7.47 2017-09-22 4 A 0 7500 0.00 A 2027-09-21 Common Stock 7500 7500 D The shares subject to the option shall vest in 12 equal monthly installments commencing on June 1, 2017, subject to the Reporting Person's continuous service to the Issuer as of each such date. The option allows for early exercise by the Reporting Person. /s/ Sujal Shah, Attorney-in-Fact 2017-09-26